| Variables | Carbapenemase production | OR brute | IC 95% OR | p-value | ||
| No | Yes | |||||
| Sex |
|
|
| |||
|
| F | 52 (77.61%) | 15 (22.39%) | 1 | Ref |
|
| M | 26 (70.27%) | 11(29.73%) | 1.46 | [0.36; 9.59] | 0.47 | |
| Age (year) |
|
|
| |||
|
| Middle age ± SD | 40.83 ans ± 5.66 | 33.91 ans ± 10.80 | 0.99 | [0.97; 1.01] | 0.33 |
| Hospitalization |
|
|
| |||
|
| No | 28 (75.68%) | 9 (24.32%) | 1 | Ref | |
|
| Yes | 50 (74.63%) | 17 (25.37%) | 1.09 | [0.57; 3.65] | 0.44 |
| Microorganisms |
|
|
| |||
|
| C. freundii | 11 (84.62%) | 2 (15.38%) | 1 | Ref |
|
|
| K. pneumoniae | 22 (56.4%) | 17 (43.6%) | 3.82 | [3.15; 7.80] | 0.01 |
|
| E. coli | 45 (86.54%) | 7 (13.46%) | 0.86 | [0.12; 3.65] | 0.63 |
| AmpC-production |
|
|
|
|
| |
|
| No | 66 (82.50%) | 14 (17.50%) | 1 | Ref |
|
|
| Yes | 12 (50.00%) | 12 (50.00%) | 4.71 | [3.92; 5.05] | 0.001 |
| ESBL-production |
|
|
|
|
| |
|
| No | 53 (80.30%) | 13 (19.70%) | 1 | Ref |
|
|
| Yes | 25 (65.79%) | 13 (34.21%) | 2.12 | [1.82; 3.65] | 0.01 |